WHO: Beijing welcomes COVID-19 investigations
Geneve – Beijing will welcome an international team of COVID-19 investigators due to travel to China in January, said the World Health Organization (WHO), which is leading the mission. China has strongly opposed calls for an international inquiry into the … Continue reading WHO: Beijing welcomes COVID-19 investigations
Covid-19: Baricitinib plus remdesivir shows promising
Washington – The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people hospitalized with COVID-19, according to clinical trial results published in the New England Journal of Medicine. The study was supported by the … Continue reading Covid-19: Baricitinib plus remdesivir shows promising
COVID Vaccine: Moderna is conducting a clinical trial
Washington – Moderna has finished accumulating data for a first analysis of its COVID-19 vaccine and expects to have an announcement on the vaccine’s efficacy by the end of the month, the company said in a statement Wednesday. Pfizer announced Monday that … Continue reading COVID Vaccine: Moderna is conducting a clinical trial
COVID-19: NIH begins large clinical trial
Washington – The National Institutes of Health has launched an adaptive Phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19. Some COVID-19 patients experience an immune response in which … Continue reading COVID-19: NIH begins large clinical trial
NIH study identifies promising COVID-19 treatments
Washington – The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, today launched a study designed to determine whether certain approved therapies or investigational drugs in late-stage clinical development show promise against COVID-19 … Continue reading NIH study identifies promising COVID-19 treatments